Role of bisphosphonates in metabolic bone diseases
作者： Neveen A.T. Hamdy
DOI: 10.1016/1043-2760(93)90059-N
关键词:
摘要: Bisphosphonates are potent inhibitors of osteoclast-mediated bone resorption and represent the treatment choice in disorders associated with accelerated resorption. They widely used management Paget's disease hypercalcemia malignancy. Over past few years, evidence has been accumulating for a beneficial effect these agents tumor-induced osteolytic established osteoporosis. may also play useful though limited role medical hyperparathyroidism heterotopic ossification.
sci-hub.se 参考文章(51)
Olav L. M. Bijvoet, Disodium Pamidronate Therapy of Paget’s Disease Springer, Boston, MA. pp. 100- 111 ,(1991) , 10.1007/978-1-4684-2307-5_9
John A. Kanis, Pathophysiology and Treatment of Paget's Disease of Bone ,(1991)
Pierre J. Meunier, Alain Ravault, Treatment of Paget’s Disease with Etidronate Disodium Springer, Boston, MA. pp. 86- 99 ,(1991) , 10.1007/978-1-4684-2307-5_8
I. Elomaa, C. Blomqvist, P. Gröhn, L. Porkka, A.-L. Kairento, K. Selander, C. Lamberg-Allardt, T. Holmström, Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases. The Lancet. ,vol. 321, pp. 146- 149 ,(1983) , 10.1016/S0140-6736(83)92755-1
J.Y. Reginster, A.M. Jeugmans-Huynen, A. Albert, D. Denis, R. Deroisy, M.P. Lecart, M.A. Fontaine, J. Collette, P. Franchimont, Biological and clinical assessment of a new bisphosphonate, (chloro-4 phenyl)thiomethylene bisphosphonate, in the treatment of Paget's disease of bone Bone. ,vol. 9, pp. 349- 354 ,(1988) , 10.1016/8756-3282(88)90115-9
Tommy Storm, Gorm Thamsborg, Torben Steiniche, Harry K. Genant, Ole Helmer Sorensen, Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal Osteoporosis New England Journal of Medicine. ,vol. 322, pp. 1265- 1271 ,(1990) , 10.1056/NEJM199005033221803
G R Mundy, Hypercalcemia of malignancy revisited. Journal of Clinical Investigation. ,vol. 82, pp. 1- 6 ,(1988) , 10.1172/JCI113555
Angelique T.M. van Holten-Verzantvoort, Aeilko H. Zwinderman, Neil K. Aaronson, Jo Hermans, Beatrix van Emmerik, Frits S.A.M. van Dam, Birgit van den Bos, Olav L.M. Bijvoet, Frans J. Cleton, The effect of supportive pamidronate treatment on aspects of quality of life of patients with advanced breast cancer European Journal of Cancer and Clinical Oncology. ,vol. 27, pp. 544- 549 ,(1991) , 10.1016/0277-5379(91)90212-V
Hubertus I.J. Harinck, Olav L.M. Bijvoet, AndréS.T. Plantingh, Jean-Jacques Body, Jan Willem F. Elte, Harm P. Sleeboom, Johan Wildiers, Jan P. Neijt, Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chloride The American Journal of Medicine. ,vol. 82, pp. 1133- 1142 ,(1987) , 10.1016/0002-9343(87)90215-4
Herbert Fleisch, Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease. Drugs. ,vol. 42, pp. 919- 944 ,(1991) , 10.2165/00003495-199142060-00003